Investor Update

Basel, 01 July 2011

Chronic Hepatitis C Treatment, Pegasys®, and Antiviral Drug, Copegus®, Obtained Approval for Additional Indication of Compensated Liver Cirrhosis Related to Hepatitis C

Dear Investor,

Please find attached a press release by Chugai.

Do not hesitate to contact us for any further questions.